Simulations Plus Cost of Goods Sold 2010-2024 | SLP
Simulations Plus cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Simulations Plus Annual Cost of Goods Sold
(Millions of US $) |
| 2024 |
$27 |
| 2023 |
$12 |
| 2022 |
$11 |
| 2021 |
$11 |
| 2020 |
$11 |
| 2019 |
$9 |
| 2018 |
$8 |
| 2017 |
$6 |
| 2016 |
$5 |
| 2015 |
$4 |
| 2014 |
$2 |
| 2013 |
$2 |
| 2012 |
$2 |
| 2011 |
$2 |
| 2010 |
$3 |
| 2009 |
$2 |
Simulations Plus Quarterly Cost of Goods Sold
(Millions of US $) |
| 2024-08-31 |
$12 |
| 2024-05-31 |
$5 |
| 2024-02-29 |
$5 |
| 2023-11-30 |
$5 |
| 2023-08-31 |
$3 |
| 2023-05-31 |
$3 |
| 2023-02-28 |
$3 |
| 2022-11-30 |
$3 |
| 2022-08-31 |
$3 |
| 2022-05-31 |
$3 |
| 2022-02-28 |
$3 |
| 2021-11-30 |
$3 |
| 2021-08-31 |
$3 |
| 2021-05-31 |
$2 |
| 2021-02-28 |
$3 |
| 2020-11-30 |
$2 |
| 2020-08-31 |
$3 |
| 2020-05-31 |
$3 |
| 2020-02-29 |
$3 |
| 2019-11-30 |
$3 |
| 2019-08-31 |
$2 |
| 2019-05-31 |
$2 |
| 2019-02-28 |
$2 |
| 2018-11-30 |
$2 |
| 2018-08-31 |
$2 |
| 2018-05-31 |
$2 |
| 2018-02-28 |
$2 |
| 2017-11-30 |
$2 |
| 2017-08-31 |
$2 |
| 2017-05-31 |
$1 |
| 2017-02-28 |
$2 |
| 2016-11-30 |
$1 |
| 2016-08-31 |
$1 |
| 2016-05-31 |
$1 |
| 2016-02-29 |
$1 |
| 2015-11-30 |
$1 |
| 2015-08-31 |
$1 |
| 2015-05-31 |
$1 |
| 2015-02-28 |
$1 |
| 2014-11-30 |
$1 |
| 2014-08-31 |
$0 |
| 2014-05-31 |
$0 |
| 2014-02-28 |
$0 |
| 2013-11-30 |
$0 |
| 2013-08-31 |
$0 |
| 2013-05-31 |
$0 |
| 2013-02-28 |
$0 |
| 2012-11-30 |
$0 |
| 2012-08-31 |
$0 |
| 2012-05-31 |
$0 |
| 2012-02-29 |
$0 |
| 2011-11-30 |
$0 |
| 2011-08-31 |
$0 |
| 2011-05-31 |
$0 |
| 2011-02-28 |
$0 |
| 2010-11-30 |
$0 |
| 2010-08-31 |
$1 |
| 2010-05-31 |
$1 |
| 2010-02-28 |
$1 |
| 2009-11-30 |
$1 |
| 2009-08-31 |
$1 |
| 2009-05-31 |
$1 |
| 2009-02-28 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.552B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
